2024 annual financial data
Processa Pharmaceuticals 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -12,051,206 USD and net income was -11,850,118 USD.
Operating cash flow was -11,245,042 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,051,206 USD
- Net income
- -11,850,118 USD
- Operating cash flow
- -11,245,042 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Processa Pharmaceuticals financial years